Author: Çelik, Hülya Gamze; Keske, Şiran; Şener, Ülker; Tekbaş, Müge; Kapmaz, Mahir; Şahin, Şükrü Taylan; Özyıldırım, Aslı; Aytekin, Saide; Aytekin, Vedat; Ergönül, Önder
Title: Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic? Cord-id: uq0j0n1u Document date: 2020_10_29
ID: uq0j0n1u
Snippet: The aim of this study was to describe the QTc prolongation and related adverse cardiac events during the administration of hydroxychloroquine (HCQ) and its combinations for the treatment of coronavirus disease 2019 (COVID-19). Hospitalized patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who received HCQ and had initial and follow-up electrocardiograms performed between March 10 and May 30, 2020 were included. Critical QTc prolongation was detected in 12% of th
Document: The aim of this study was to describe the QTc prolongation and related adverse cardiac events during the administration of hydroxychloroquine (HCQ) and its combinations for the treatment of coronavirus disease 2019 (COVID-19). Hospitalized patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who received HCQ and had initial and follow-up electrocardiograms performed between March 10 and May 30, 2020 were included. Critical QTc prolongation was detected in 12% of the patients. On multivariate analysis, diabetes mellitus (odds ratio 5.8, 95% confidence interval 1.11–30.32, p = 0.037) and the use of oseltamivir (odds ratio 5.3, 95% confidence interval 1.02–28, p = 0.047) were found to be associated with critical QTc prolongation.
Search related documents:
Co phrase search for related documents- admission rate and long duration: 1, 2
- admission rate and lupus erythematosus: 1
Co phrase search for related documents, hyperlinks ordered by date